A Legacy of Enhancing Collaborations
Advancing research and improving the kind and quality of care available are key ingredients in improving outcomes and health of people living with SCI. Both are essential for strengthening individuals, families, caregivers and communities, for reducing the high cost of SCI to society as a whole, and for achieving scientific breakthroughs that hold the promise of better lives.
The Blusson Integrated Cures Partnership (BICP), a collaboration between ICORD and Praxis Spinal Cord Institute between 2013 and 2020, was established to do just this.
In April 2013, the Rick Hansen Foundation (RHF), a leader in accessibility and awareness, committed $20-million over ten years to support researchers and clinicians at the Blusson Spinal Cord Centre to accelerate preclinical and clinical research in SCI. This funding was aimed at strengthening the partnership between Praxis and ICORD, and leveraging their existing strengths for greater impact.
The purpose of the BICP partnership was to:
- become the world’s leading partnership in innovative and collaborative preclinical and clinical research to accelerate the discovery of SCI cures;
- develop and promote an International Clinical Trial and Research Network to enable international collaboration in promising clinical trials and research efforts; and
- inform and empower people with SCI so that they could become champions and active participants in creating a world without paralysis after SCI.